Judgment of the General Court of 24 April 2024 – Verla-Pharm Arzneimittel v EUIPO – Converso (Pherla)

(Case T-357/23)  (1)

(EU trade mark - Opposition proceedings - Application for the EU figurative mark Pherla - Earlier EU word mark VERLA - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)

(C/2024/3613)

Language of the case: English

Parties

Applicant: Verla-Pharm Arzneimittel GmbH & Co. KG (Tutzing, Germany) (represented by: M.-C. Seiler, lawyer)

Defendant: European Union Intellectual Property Office (represented by: T. Frydendahl, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Valeria Converso (San Giorgio a Cremano, Italy) (represented by F. Musella, lawyer)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Second Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 7 February 2023 (Case R 268/2022-2).

Operative part of the judgment

The Court:

(1)   OJ C 296, 21.8.2023.